Author:
McSheehy P.M.J.,Seymour M.T.,Ojugo A.S.E.,Rodrigues L.M.,Leach M.O.,Judson I.R.,Griffiths J.R.
Reference44 articles.
1. Preclinical and clinical aspects of biomodulation of 5-fluorouracil;Sotos;Cancer Treat Rev,1994
2. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer HCT-8 sublines following exposure to two different clinically relevant dose schedules;Aschele;Cancer Res,1992
3. Enzymes of uracil catabolism in normal and neoplastic human tissues;Naguib;Cancer Res,1985
4. Rustum YM, Harstrick A, Cao S, et al. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 1997, 15, 389–400.
5. 5-fluorouracil metabolism monitored in vivo by 19F-NMR;Stevens;Br J Cancer,1984
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献